HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

RG-1507 monoclonal antibody

a fully human monoclonal antibody directed against the Type 1 Insulin-like Growth Factor Receptor

Also Known As:

RG 1507; RG-1507; RG1507

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Blood Proteins: 12459
    - Serum Globulins: 553
      - Immunoglobulins: 30480
        Antibodies: 133716
        Monoclonal Antibodies: 56412
        RG-1507 monoclonal antibody: 1
    - Immunoproteins: 43
      - Immunoglobulins: 30480
        Antibodies: 133716
        Monoclonal Antibodies: 56412
        RG-1507 monoclonal antibody: 1
  - Globulins: 3062
    - Serum Globulins: 553
      - Immunoglobulins: 30480
        Antibodies: 133716
        Monoclonal Antibodies: 56412
        RG-1507 monoclonal antibody: 1

Experts

1.	Aikin, A: 1 article (02/2011)
2.	Bagatell, R: 1 article (02/2011)
3.	Balis, F M: 1 article (02/2011)
4.	Bish, J: 1 article (02/2011)
5.	Cirrincione-Dall, G: 1 article (02/2011)
6.	Fox, E: 1 article (02/2011)
7.	Gore, L: 1 article (02/2011)
8.	Grippo, J F: 1 article (02/2011)
9.	Herzog, C E: 1 article (02/2011)
10.	Macy, M: 1 article (02/2011)

Related Diseases

1.

Neoplasms (Cancer)

02/01/2011 - "The recommended doses of RG1507 in children with solid tumors are 9 mg/kg/wk and 16 mg/kg q3W. "
02/01/2011 - "Children with relapsed or refractory solid tumors were treated using the same doses and administration schedules of RG1507 (3 and 9 mg/kg/wk, and 16 mg/kg every 3 weeks [q3W]) as those studied in adults. "
02/01/2011 - "Pharmacokinetically guided phase 1 trial of the IGF-1 receptor antagonist RG1507 in children with recurrent or refractory solid tumors."

Related Drugs and Biologics

1.	IGF Type 1 Receptor (IGF 1 Receptor)